Progestogen potency in oral contraceptive pills.

Area of Science:

• Reproductive endocrinology
• Pharmacology of oral contraceptives

Background:

• Combined oral contraceptives (COCs) primarily act on the anterior pituitary gland and uterus.
• Ununopposed estrogen can lead to endometrial hyperplasia and amenorrhea, which are undesirable side effects.
• Cyclic progestogen-estrogen administration is crucial for achieving acceptable menstrual bleeding patterns.

Purpose of the Study:

• To review the literature on the comparative potencies of progestogens.
• To address the inappropriate extrapolation of endometrial-based progestogen potency data to other organ systems.
• To highlight the organ-specific effects of progestogens and estrogens.

Main Methods:

• Literature review on the effects of progestogens and estrogens on target organs.
• Analysis of the "delay of menses" test for comparing oral progestogen potencies.
• Discussion of the limitations of extrapolating endometrial study data.

Main Results:

• The "delay of menses" test was historically used to compare oral progestogen potencies.
• Extrapolating progestogen potency from endometrial studies to other organs is scientifically inappropriate.
• The effects of progestogens and estrogens vary significantly across different target organs.

Conclusions:

• Progestogen potency is target-organ specific.
• Endometrial effects do not accurately predict effects on other systems like the pituitary.
• A nuanced approach is needed when evaluating the efficacy and side effects of combined oral contraceptives.